Exploration of the potential therapeutic benefits of naringenin against diabetic retinopathy through a National comprehensive cross-sectional study and in vitro experiments.

Diabetol Metab Syndr · 2025 · PMC12315193 · PMID 40751167

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a clear trendP = 0.06so close (0.05 < p ≤ 0.1)

did not reach statistical significanceno p-value reported

Although a clear trend was observed ( P = 0.06), the difference did not reach statistical significance, presenting an apparent contradiction with the in vitro findings.

also in 13,370 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.